Fairvalue-Calculator Fairvalue-Calculator
EN DE

Creo Medical Group (CMEOF) Fair Value & Analysis

Healthcare · US · Market cap $97.2M

Price$0.2000
Fair Value$0.1200
Upside-40.0%
Quality91/100
Evidence: Medium Range $0.1100 – $0.1500

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Creo Medical Group (CMEOF) currently trades at $0.2000, while our model-based Fair Value estimate is $0.1200 — implying the stock looks roughly 40.0% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a microwave ablation device designed for soft tissue ablation; and SpydrBlade Flex, a multi-modal endoscopic scissor-type device. In addition, it provides endotherapy accessories comprising injection needles, haemostatic clips, snares, and forceps, as well as other products for gastroenterology, pulmonology, and urology. Further, the company offers products for diagnostic, therapeutic, and hygiene purposes. …

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -95% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -27% Boston Scientific Corporation (B1SX34) -11% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Creo Medical Group (CMEOF) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.1200 versus a price of $0.2000 — about −40% (overvalued). Model-based estimate, not financial advice.
What is the fair value of CMEOF?
Our 21-model fair value for Creo Medical Group is $0.1200 (as of Jun 24, 2026), built from audited fundamentals. The current price is $0.2000.
What is the quality score of CMEOF?
Creo Medical Group has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.